Jin Medical International Received Letter From Nasdaq Informing The Company That It Regained Compliance With Filing Requirement In Listing Rule 5250(C) Regarding Filing Of Annual Report
Jin Medical International Received Letter From Nasdaq Informing The Company That It Regained Compliance With Filing Requirement In Listing Rule 5250(C) Regarding Filing Of Annual Report
Jin Medical International收到纳斯达克的来信,通知该公司已恢复遵守上市规则5250(C)中关于提交年度报告的申报要求
Jin Medical International Received Letter From Nasdaq Informing The Company That It Regained Compliance With Filing Requirement In Listing Rule 5250(C) Regarding Filing Of Annual Report
Jin Medical International收到纳斯达克的来信,通知该公司已恢复遵守上市规则5250(C)中关于提交年度报告的申报要求